Should D5W be discontinued in a patient with a blood pressure of 60/40 mm Hg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

D5W Should NOT Be Discontinued – It Should Be Used for Resuscitation

In a patient with profound hypotension (BP 60/40 mmHg), D5W should NOT be discontinued; rather, it should be REPLACED with normal saline for aggressive volume resuscitation, which is the priority intervention alongside immediate epinephrine administration.

Immediate Management Algorithm

Step 1: Assess for Life-Threatening Hypotension

A blood pressure of 60/40 mmHg represents profound hypotension requiring immediate intervention to prevent end-organ damage and mortality. This is a medical emergency.

Step 2: Fluid Resuscitation - Replace D5W with Normal Saline

Normal saline is the fluid of choice for hypotensive resuscitation 1. The guidelines are explicit about this:

  • Administer 1-2 L of normal saline to adults at 5-10 mL/kg in the first 5 minutes 1
  • D5W is specifically contraindicated for volume resuscitation because dextrose is rapidly extravasated from the intravascular circulation to interstitial tissues 1
  • Lactated Ringer's may contribute to metabolic acidosis 1

Critical pitfall: D5W provides no effective intravascular volume expansion. In profound hypotension, up to 50% of intravascular fluid can transfer to extravascular space within 10 minutes, and crystalloids up to 7 L may be necessary 1.

Step 3: Determine the Underlying Cause

The management diverges based on etiology:

If Anaphylaxis is Present:

  • Immediate intramuscular epinephrine 0.2-0.5 mL (1:1000) into the anterolateral thigh, repeat every 5 minutes as needed 1
  • Place patient supine with legs elevated 1
  • Administer oxygen 6-8 L/min 1
  • Only after failed response to IM epinephrine and volume replacement: Consider IV epinephrine infusion prepared in D5W (1 mg in 250 mL D5W = 4 mcg/mL) 1

If Refractory Hypotension After Volume Resuscitation:

  • Dopamine 400 mg in 500 mL D5W at 2-20 mcg/kg/min with continuous hemodynamic monitoring 1

Step 4: Context-Specific Considerations

If the patient has heart failure with reduced ejection fraction (HFrEF):

  • Asymptomatic or mildly symptomatic low BP should NOT prompt medication discontinuation 2
  • However, systolic BP <80 mmHg or symptomatic hypotension warrants GDMT reduction 2
  • Look for reversible causes: volume depletion, infection, medication interactions 2

If the patient is on chronic antihypertensives:

  • Recent evidence shows that discontinuing antihypertensives during acute illness increases mortality risk (OR 2.69 for in-hospital mortality, OR 1.81 for 90-day mortality) 3
  • However, at BP 60/40 mmHg, temporary holding of antihypertensives is appropriate while addressing the acute cause

The Role of D5W in This Context

D5W serves specific purposes but NOT for volume resuscitation:

  1. As a carrier solution for vasoactive medications (epinephrine infusions, dopamine) 1
  2. For diluting certain medications (ranitidine can be diluted in D5W) 1

D5W should be discontinued as the primary IV fluid and replaced with normal saline for volume expansion.

Common Pitfalls to Avoid

  • Never use D5W for volume resuscitation – it provides no sustained intravascular volume
  • Do not delay epinephrine if anaphylaxis is suspected – it is the first-line treatment with no absolute contraindications 1
  • Avoid IV epinephrine as first-line – use IM route first; IV epinephrine is reserved for cardiac arrest or profound hypotension unresponsive to IM doses and fluids 1
  • Monitor for volume overload in patients with heart failure or chronic kidney disease during aggressive fluid resuscitation 1

Monitoring Requirements

  • Blood pressure every 1-5 minutes initially
  • Continuous cardiac monitoring if available
  • Assess for signs of end-organ hypoperfusion (mental status, urine output, skin perfusion)
  • If using IV epinephrine or vasopressors, continuous hemodynamic monitoring is essential 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.